Model for end-stage liver disease score-based allocation of donors for liver transplantation:: A Spanish multicenter experience

被引:37
作者
de la Mata, Manuel
Cuende, Natividad
Huet, Jesus
Bernardos, Angel
Ferron, Jose Antonio
Santoyo, Julio
Pascasio, Juan Manuel
Rodrigo, Juan
Solorzano, Guillermo
Martin-Vivaldi, Rafael
Alonso, Manuel
机构
[1] Reina Sofia Univ Hosp, Hepatol Sect, Liver Transplant Unit, Cordoba 14004, Spain
[2] Adalusian Transplant Coordinating Off, Seville, Spain
[3] Virgen Rocio Univ Hosp, Liver Transplant Unit, Seville, Spain
[4] Virgen Nieves Univ Hosp, Liver Transplant Unit, Granada, Spain
[5] Carlos Haya Univ Hosp, Liver Transplant Unit, Malaga, Spain
关键词
prioritization; hepatocellular carcinoma; donor allocation; mortality; waiting list;
D O I
10.1097/01.tp.0000244559.60989.5a
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Prioritizing the liver transplant waiting list (WL) is subject to great variability. We present the experience of four transplant centers in Andalusia (Southern Spain) with a new consensus model of WL management based on the Model for End-Stage Liver Disease (MELD) score. Methods. The initial criteria for local prioritizing were: a) cirrhosis with MELD score :24, and b) all hepatocellular carcinoma (HCC) admitted to the WL. Fourteen months later new criteria were established: a) cirrhosis with MELD score >= 18, and b) uninodular HCC between 3-5 cm or multinodular HCC (2-3 nodules < 3 cm). Access to regional priority was scheduled after three months for patients with cirrhosis or six months for patients with HCC. We analyzed the WL mortality rate, posttransplant survival rate, and overall survival rate over three 14-month periods: A (before implementation of priority criteria), B (initial criteria), and C (current criteria). Results. Priority was given to 36% of recipients in period B and 47% in period C. The WL mortality rate (including removals from WL) was 12.9%, 12.9%, and 10.7% in periods A, B, and C, respectively. One-year graft survival was 79.7%, 72.6%, and 81.2% in the same periods. The overall one-year survival rate for new cases on the WL was 74.9% in period A, 68.6% in period B, and 82.2% in period C. Conclusions. The allocation system and WL management with the current criteria resulted in lower waiting list mortality without reducing posttransplant survival, leading to better survival for all patients listed.
引用
收藏
页码:1429 / 1435
页数:7
相关论文
共 32 条
[1]  
ALONSO M, 2002, TRANSPLANTE HEPATICO
[2]  
ALTHOFF KM, 2004, LIVER TRANSPLANT, V10, pA6
[3]  
BACKMAN I, 2005, TRANSPLANTATION LIVE, P79
[4]   Serum sodium predicts mortality in patients listed for liver transplantation [J].
Biggins, SW ;
Rodriguez, HJ ;
Bacchetti, P ;
Bass, NM ;
Roberts, JP ;
Terrault, NA .
HEPATOLOGY, 2005, 41 (01) :32-39
[5]   MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study [J].
Botta, F ;
Giannini, E ;
Romagnoli, P ;
Fasoli, A ;
Malfatti, F ;
Testa, E ;
Risso, D ;
Colla, G ;
Testa, R .
GUT, 2003, 52 (01) :134-139
[6]   Model for End-Stage Liver Disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients [J].
Brown, RS ;
Kumar, KS ;
Russo, MW ;
Kinkhabwala, M ;
Rudow, DL ;
Harren, P ;
Lobritto, S ;
Emond, JC .
LIVER TRANSPLANTATION, 2002, 8 (03) :278-284
[7]   Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].
Bruix, J ;
Sherman, M ;
Llovet, JM ;
Beaugrand, M ;
Lencioni, R ;
Burroughs, AK ;
Christensen, E ;
Pagliaro, L ;
Colombo, M ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430
[8]   Prognostic models including the Child-Pugh, MELD and Mayo risk scores - where are we and where should we go? [J].
Christensen, E .
JOURNAL OF HEPATOLOGY, 2004, 41 (02) :344-350
[9]   Priority criteria for the access to transplantation. The case of liver transplant in Spain [J].
Cuende Melero, N ;
Serrano, BM ;
Campos, JFC ;
Nieto, TN ;
Cantarero, GG .
MEDICINA CLINICA, 2003, 120 (10) :380-386
[10]  
DELAMATA M, 2004, GASTROENTEROL HEP S4, V27, P62